Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells

Molecular Pharmaceutics

Volumn 6, Issue 5, 2009, Pages 1402-1408

  Balasubramanian, Priya ^a   Yang, Liying ^a   Lang, James C ^b   Jatana, Kris R ^b   Schuller, David ^b   Agrawal, Amit ^b   Zborowski, Maciej ^c   Chalmers, Jeffrey J ^a,d  

^a Ohio State University   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d University Cell Analysis and Sorting Core   (United States)

Author keywords

Circulating tumor cells; Head and neck squamous cell carcinoma (HNSCC); Immunocytochemistry; Immunomagnetic cell separation; RT PCR

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; CYTOKERATIN; EPIDERMAL GROWTH FACTOR RECEPTOR;

BLOOD SAMPLING; CANCER PATIENT; CANCER SURGERY; CELL NUCLEUS; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CYTOPLASM; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

BASE SEQUENCE; CELL LINE, TUMOR; DNA PRIMERS; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; HUMANS; IMMUNOMAGNETIC SEPARATION; KERATINS; MICROSCOPY, CONFOCAL; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 70350075950     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp9000519     Document Type: Conference Paper

References (36)

1. Fehm, T. Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance. Breast Cancer Res 2008, 10 (Suppl. 1), S1.
2. Pantel, K.; Brakenhoff, R. H.; Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 2008, 8 (5), 329-340
3. Pantel, K.; Brakenhoff, R. H. Dissecting the metastatic cascade. Nat. Rev. Cancer 2004, 4 (6), 448-456
4. Schmidt-Kittler, O. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (13), 7737-7742 (Pubitemid 36760039)
5. Klein, C. A. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 2002, 360 (9334), 683-689
6. Klein, C. A. Combined transcriptome and genome analysis of single micrometastatic cells. Nat. Biotechnol. 2002, 20 (4), 387-392
7. Braun, S. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 2005, 353 (8), 793-802. (Pubitemid 41215488)
8. Cristofanilli, M. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 2004, 351 (8), 781-791 (Pubitemid 39095313)
9. Riethdorf, S. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the CellSearch system. Clin. Cancer Res. 2007, 13 (3), 920-928 (Pubitemid 46340368)
10. Fehm, T. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin. Cancer Res. 2002, 8 (7), 2073-2084 (Pubitemid 34753576)
11. Hayes, D. F. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. Int. J. Oncol. 2002, 21 (5), 1111-1117
12. Racila, E. Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. U.S.A. 1998, 95 (8), 4589-4594
13. Meng, S. HER-2 gene amplification can be acquired as breast cancer progresses. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (25), 9393-9398 (Pubitemid 38812885)
14. Reimers, N. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin. Cancer Res. 2004, 10 (10), 3422-3428 (Pubitemid 38685448)
15. Hemsen, A. Comparative evaluation of urokinase-type plasminogen activator receptor expression in primary breast carcinomas and on metastatic tumor cells. Int. J. Cancer 2003, 107 (6), 903-909 (Pubitemid 37429831)
16. Braun, S. ErbB2 overexpression on occult metastatic cells in bone marrow predicts poor clinical outcome of stage I-III breast cancer patients. Cancer Res. 2001, 61 (5), 1890-1895 (Pubitemid 32692004)
17. Braun, S. Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int. J. Cancer 1999, 84 (1), 1-5. (Pubitemid 29059099)
18. Pantel, K. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J. Natl. Cancer Inst. 1993, 85 (17), 1419-1424 (Pubitemid 23264351)
19. Pantel, K. Frequent down-regulation of major histocompatibility class I antigen expression on individual micrometastatic carcinoma cells. Cancer Res. 1991, 51 (17), 4712-4715
20. Schlimok, G.; Riethmuller, G. Detection, characterization and tumorigenicity of disseminated tumor cells in human bone marrow. Semin. Cancer Biol. 1990, 1 (3), 207-215
21. Partridge, M. Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. Clin. Cancer Res. 2003, 9 (14), 5287-5294 (Pubitemid 37413581)
22. Nagrath, S. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450 (7173), 1235-1239
23. Zheng, S. Membrane microfilter device for selective capture, electrolysis and genomic analysis of human circulating tumor cells. J. Chromatogr. A 2007, 1162 (2), 154-161 (Pubitemid 47187403)
24. Yang, L. Optimization of an enrichment process for circulating tumor cells from the blood of head and neck cancer patients through depletion of normal cells. Biotechnol. Bioeng. 2009, 102 (2), 521-534
25. Tong, X. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood. Cytometry, Part B 2007, 72 (5), 310-323
26. Al-Hajj, M. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7), 3983-3988 (Pubitemid 36418143)
27. Collins, A. T. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005, 65 (23), 10946-10951 (Pubitemid 41713363)
28. O'Brien, C. A. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445 (7123), 106-110
29. Singh, S. K. Identification of human brain tumour initiating cells. Nature 2004, 432 (7015), 396-401. (Pubitemid 39551674)
30. Lee, C. J.; Li, C.; Simeone, D. M. Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer. Transl. Oncol. 2008, 1 (1), 14-18
31. Prince, M. E. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (3), 973-978 (Pubitemid 46154721)
32. Reya, T. Stem cells, cancer, and cancer stem cells. Nature 2001, 414 (6859), 105-111
33. Chaffer, C. L.; Thompson, E. W.; Williams, E. D. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 2007, 185 (1-3), 7-19. (Pubitemid 46956838)
34. Berx, G. Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis 2007, 24 (8), 587-597 (Pubitemid 50000849)
35. Sarrio, D. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 2008, 68 (4), 989-997 (Pubitemid 351272216)
36. Bagnato, A.; Rosano, L. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis. Cells Tissues Organs 2007, 185 (1-3), 5-94. (Pubitemid 46956847)